Finance
King Charles' cancer treatment progressing well, will continue next year
Published by Global Banking & Finance Review®
Posted on December 20, 2024
1 min readLast updated: January 27, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on December 20, 2024
1 min readLast updated: January 27, 2026
King Charles' cancer treatment is progressing well and will continue into 2025, with no significant health changes reported.
LONDON (Reuters) - King Charles' cancer treatment is progressing well and will continue into next year, a Buckingham Palace source said on Friday.
In February, the palace revealed the 76-year-old, who became king in 2022, had been diagnosed with an unspecified form of cancer detected in tests after a corrective procedure for an enlarged prostate. He returned to public duties in April.
"His treatment has been moving in a positive direction and as a managed condition the treatment cycle will continue into next year," the palace source said.
Charles' medical team has carefully monitored the monarch's official engagements since he returned to public life.
The palace source said there had been no change in Charles' health and the news that his treatment would continue in 2025 did not represent any significant update.
In October, Charles and his wife Camilla made a brief stopover in India where they stayed at a holistic health centre following his first major trip since being diagnosed with cancer to Australia and Samoa.
(Reporting by Michael Holden; Writing by Catarina Demony; Editing by Kate Holton)
The main topic is King Charles' ongoing cancer treatment and its progress.
King Charles' health is stable with no significant changes, and his treatment is progressing well.
King Charles recently traveled to India and visited a holistic health center.
Explore more articles in the Finance category
